Republicans Plan to Codify Trump’s Prescription Drug Price Cap for Midterm Advantage
U.S. President Donald Trump gestures on the day he signs an executive order on prescription drug pricing, next to U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., during a press conference in the Roosevelt Room at the White House in Washington, D.C., U.S., May 12, 2025. REUTERS/Nathan Howard
By Newsmax Wires | Monday, December 29, 2025 at 3:34 p.m. EST
Republicans could gain a political edge in the upcoming election by codifying President Donald Trump’s executive actions on prescription drug pricing, a move that would lower costs and energize voters, according to Representative Anna Paulina Luna of Florida.
Luna stated that Republicans see unfinished business in Washington and believe healthcare affordability could become one of their strongest issues heading into the midterms. “There’s a ton that we’re still going to do, and I think one of the biggest winning issues will be if a Republican Congress can codify President Trump’s executive order on capping prescription prices,” she said. “I am hopeful that they will do.”
Trump announced on December 19 that nine major pharmaceutical companies have agreed to lower prescription drug costs in the United States. These companies—Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi—will now cap Medicaid drug prices at levels they charge in other developed countries.
As part of the deal, new medications from these companies will be priced under a “most-favored-nation” framework across the country, including commercial and cash-pay markets as well as Medicare and Medicaid.
Luna emphasized that action on prescription pricing could shift momentum toward Republicans ahead of the midterms. “If that happens, the midterms are with us, the winds are in our sail, and we win—bringing prosperity to Americans,” she added.
The remarks reflect a Republican push to regain ground on healthcare, an issue Democrats have often dominated. By focusing on prescription drug prices, Republicans hope to appeal to seniors, working families, and voters frustrated by inflation and rising medical costs. Democrats, meanwhile, have highlighted their legislative accomplishments, including provisions in the Inflation Reduction Act that allow Medicare to negotiate certain drug prices and cap insulin costs for some seniors.
